A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder

Pregnant and postpartum women (PPW) with substance use disorders (SUDs) face high levels of self-stigma, the internalization of negative feelings about oneself because of drug misuse. Self-stigma is highly correlated with numerous detrimental consequences including recovery outcomes and reduced engagement with SUD treatment. Furthermore, self-stigma prevents treatment initiation and engagement among PPW with SUDs, leading to additional adverse health outcomes for both mother and baby. Digital interventions have the potential to support healthier behaviors among PPW with SUDs and may also provide a promising method for reducing their self-stigma. Enhearten is a digital intervention that has been enhanced to foster adherence to medications for addiction treatment (MAT) while considering the unique needs of PPW, but its effects on self-stigma, treatment retention, and SUD outcomes have not been rigorously tested. In this study, the investigators will test this augmented version of Enhearten with a stigma-focused ecological momentary intervention (EMI) designed to: 1) screen for feelings of stigma and 2) counteract these vulnerabilities via just-in-time interventions. Specifically, the investigators will conduct an individual-level multi-center randomized control trial (RCT) to test the feasibility, acceptability, and efficacy of Enhearten on reducing self-stigma and on improving SUD treatment and recovery outcomes. Participants will be randomized to one of two groups: Enhearten with EMI or a waitlist control group (i.e., participants will have access to the intervention following the RCT). Recruitment will occur through treatment facilities and recovery homes throughout the United States, referrals from stakeholders including clinicians and peer support specialists, and approved research recruitment registries. This study will determine the efficacy and utility of Enhearten among PPW with SUDs, addressing a promising solution to supplement traditional in-person care, reduce self-stigma, and support continued motivation and adherence to treatment plans along the recovery journey.

• Use of Medications for Addiction Treatment (MAT) [Срок оценки: Baseline through 6-months post-intervention]
• Substance use [Срок оценки: Baseline through 6 months post-intervention]
• Substance use cravings [Срок оценки: Baseline through 6 months post-intervention]
• Attitudes towards using medication for addiction treatment during pregnancy/postpartum [Срок оценки: Baseline through 6 months post-intervention]
• Subjective norms towards using medication for addiction treatment [Срок оценки: Baseline through 6 months post-intervention]
• Self-efficacy towards using medication for addiction treatment [Срок оценки: Baseline through 6 months post-intervention]
• Mental health symptoms [Срок оценки: Baseline through 6 months post-intervention]
• Infant feeding intentions [Срок оценки: Baseline through 6 months post-intervention]
• Usability and usefulness of intervention [Срок оценки: 1-month post-intervention to 6-months post-intervention]
• Acceptability of intervention [Срок оценки: 1-month post-intervention to 6-months post-intervention]